Overcoming chemoresistance in non-small cell lung cancer: Insights into the influence of inflammatory factors on treatment response

Figure 2 The association between the abnormal levels of inflammatory cytokines and cisplatin resistance. A-E: Enzyme-linked immunosorbent assay was employed to measure the levels of interleukin (IL)-4 (A), IL-6 (B), IL-8 (C), IL-10 (D) and tumor necrosis factor-α (E) in tumor tissues of patients with non-small cell lung cancer who were sensitive and resistant to cisplatin. Data were presented as mean ± SD (n = 10). ^aP < 0.05, ^bP < 0.01. Statistical significance was determined using Student’s t-test. IL: Interleukin; TNF-α: Tumor necrosis factor-α.